Form 4: NeueHealth Director Stephen Kraus Reports Stock Transactions
SEC Form 4
Director Stephen Kraus reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.
Summary
- On May 12, 2024, Stephen Kraus, a director of NeueHealth, Inc., acquired 4,755 shares of common stock and disposed of 5,944 shares.
- These transactions were related to the vesting of restricted stock units.
- Kraus also acquired 10,500 restricted stock units on May 13, 2024, which will vest on May 13, 2025.
- Following these transactions, Kraus directly owns 10,500 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare industry.
Stakeholder Impact
- Shareholders are informed about the insider's stock transactions, providing transparency.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Acquisition of 4,755 shares of common stock and disposal of 5,944 shares; vesting of restricted stock units. |
| 05/13/2024 | Acquisition of 10,500 restricted stock units vesting on May 13, 2025. |
| 05/13/2025 | Vesting date for 10,500 restricted stock units. |
| 05/14/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.